Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00473278
Other study ID # 06-1067
Secondary ID
Status Completed
Phase N/A
First received May 11, 2007
Last updated January 29, 2013
Start date January 2007
Est. completion date June 2009

Study information

Verified date January 2013
Source University of Colorado, Denver
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Observational

Clinical Trial Summary

The significance of our study is in the importance of understanding the quality and quantity of proteins in the human tear film, and any unique aspects of tears in children. This pilot study will provide data to plan prospective research to better delineate the utility of tear proteins in diagnosing and following disease status in a non-invasive fashion.


Recruitment information / eligibility

Status Completed
Enrollment 2
Est. completion date June 2009
Est. primary completion date June 2009
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group N/A to 17 Years
Eligibility Inclusion Criteria:

- Less than 18 years of age

- A parent or legal guardian provide written informed consent to participate

- Able to cooperate with tear sample collection, or a previously planned sedation for other medical purposes

Exclusion Criteria:

- Age greater than or equal to 18 years

- Patients' parents or legal guardians who refuse to sign study consent

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
United States The Childrens Hospital Denver Colorado

Sponsors (1)

Lead Sponsor Collaborator
University of Colorado, Denver

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Proteome of Human Tears Single Exam No
See also
  Status Clinical Trial Phase
Recruiting NCT02500862 - Characterization of Potential Biomarkers of Eye Disease and Vision
Completed NCT02003547 - A Single Centre Study to Evaluate 3 Ophthalmic Formulations in Healthy Subjects Phase 1
Completed NCT01693315 - Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma Phase 2
Recruiting NCT02321189 - The Effect of Resveratrol Based Nutritional Supplement on Choroidal Thickness N/A
Completed NCT00073099 - Digital Photography to Evaluate Dry Eye N/A
Completed NCT00678860 - Validation of Computerized Vision-Targeted Quality-of-Life Questionnaires N/A
Completed NCT00957190 - The DIOXXACT Trial(Diurnal IOP and OBF Xalatan vs Xalatan And Cosopt Trial) Phase 4
Active, not recruiting NCT00386906 - Sentinel Lymph Node (SLN) Biopsy for Conjunctival/Eyelid Melanoma Phase 1
Completed NCT00001737 - Cyclosporin Implant to Treat Uveitis Phase 1
Completed NCT04912622 - RPE Characterisation With Transscleral Optical Phase Imaging in Retinal Disorders N/A
Recruiting NCT02321176 - Pharmacokinetics of Trans-resveratrol Based Nutritional Supplement and Its Three Metabolites in Human Eyes and Blood N/A
Completed NCT00591110 - Project inCharge: Increasing the Rate of Comprehensive Eye Care Utilization by Older African Americans Through Community-Based Eye Health Education Program N/A
Unknown status NCT00649766 - Tailored Messages to Increase Eye Examination Behavior N/A
Completed NCT02851251 - Multicenter Neonatal Eye Disease Screening in China
Active, not recruiting NCT01648452 - CNTF Implants for CNGB3 Achromatopsia Phase 1/Phase 2
Enrolling by invitation NCT01396967 - Trying a New Device for Performing Capsulorhexis in Cataract Surgery Surgery Phase 1
Completed NCT00270647 - Physicians' Health Study II N/A
Completed NCT00001224 - Analysis of Eye Tissue N/A
Terminated NCT00453258 - Pilot Study of Human Tear Proteins N/A
Recruiting NCT02821767 - Natural History, Pathogenesis, and Outcome of Ocular Disorders